Literature DB >> 11799355

Valproate therapy for chronic, combat-induced posttraumatic stress disorder.

Frederick Petty, Lori L Davis, Alexandria L Nugent, Gerald L Kramer, Andra Teten, Andrew Schmitt, Robert C Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11799355     DOI： 10.1097/00004714-200202000-00021

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  9 in total

Review 1.  Antiepileptic drugs for the treatment of post-traumatic stress disorder.

Authors:  Heather A Berlin
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

Review 2.  Comorbidity in pediatric bipolar disorder.

Authors:  Gagan Joshi; Timothy Wilens
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-04

Review 3.  Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.

Authors:  William Berger; Mauro V Mendlowicz; Carla Marques-Portella; Gustavo Kinrys; Leonardo F Fontenelle; Charles R Marmar; Ivan Figueira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-12-24       Impact factor: 5.067

4.  Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment.

Authors:  Kathryn M Connor; Jonathan R T Davidson; Richard H Weisler; Wei Zhang; Kurian Abraham
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

Review 5.  Long-term pharmacotherapy for post-traumatic stress disorder.

Authors:  Lori L Davis; Elizabeth C Frazier; Raela B Williford; Jason M Newell
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 6.  Anticonvulsants in anxiety disorders.

Authors:  Gustavo Kinrys; Lisa E Wygant
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

Review 7.  Antiepileptic drugs in the treatment of anxiety disorders: role in therapy.

Authors:  Michael Van Ameringen; Catherine Mancini; Beth Pipe; Mark Bennett
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Psychopharmacology of anxiety disorders.

Authors:  Giovanni B Cassano; Nicolò Baldini Rossi; Stefano Pini
Journal:  Dialogues Clin Neurosci       Date:  2002-09       Impact factor: 5.986

9.  Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.

Authors:  Jeffrey L Berlant
Journal:  BMC Psychiatry       Date:  2004-08-18       Impact factor: 3.630
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.